Traxion Sab De Cv Ord Shs GRPOF

RE:RE:RE:RE:RE:RE:Have they mentioned a timeline for TSX?

[JoeRoganBNN]

January 01, 2018 you'll see 2.00$ a share. However, the golden gem is currently PPP001 with DIN#. The value of having a DIN# with a lucrative market such as Cannabis is the global market place.  The value of this Ppp001 DIN# would have a value of no less $ 1 Billion US, yes one billion American dollars! Moreover, this does not include other trials put in place.  It's fair to say, a modest estimate is  Tetra Bio-Pharma will be valued similarly to GWPH in a couple years time. Late 2019, I would expect the evaluation on the TSX would be between 1.0 to 1.5 billion$ or a current SP of $8.80 to $13.20$ ps. 

Attention: Explosive growth will occur at specific times.  Likely in this order.

1.) Announcement of PPP001 commercial sales in the maritime sector. (Pre-DIN#) (Late 2017)
2.) Announcement of TSXV (Late 2017 or early 2018)
3.) Announcement of PPP001 commercial sales expanding into other provinces (Pre-DIN#) (Early to mid 2017)
4.) Announcement of positive (expected) sales for PPP001 (Early 2018)
5.) Announcement of progress r/t other clinical trials ( 10% bump up for each or vice-versa on bad news) (early 2018)
6.) Announcement of other new clinical trials (likely with increased revenues generated from sales)
7.)TSX (2018)
8.) To determine the Share Price is difficult. But, I would guesstimate an evaluation roughly between 3.50$ to 5.50$ at the current share structure leading into late 2018. 
9.) 8.80$ to 13.20$ ps by late 2019 with successful trials.


Very happy to hold my long term stake .of .01% of Tetra or 120,000 shares as of late.